Kestra Private Wealth Services, LLC Ocuphire Pharma, Inc. Transaction History
Kestra Private Wealth Services, LLC
- $6.57 Billion
- Q2 2025
A detailed history of Kestra Private Wealth Services, LLC transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 19,000 shares of OCUP stock, worth $18,620. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,000
Previous 48,341
60.7%
Holding current value
$18,620
Previous $47,000
61.7%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding OCUP
# of Institutions
50Shares Held
17.6MCall Options Held
19KPut Options Held
0-
Perceptive Advisors LLC New York, NY4.33MShares$4.24 Million0.19% of portfolio
-
Bios Capital Management, LP Fort Worth, TX3.68MShares$3.61 Million4.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.35MShares$3.28 Million0.14% of portfolio
-
Opaleye Management Inc. Boston, MA1.22MShares$1.2 Million0.29% of portfolio
-
Mink Brook Asset Management LLC West Palm Beach, FL1.2MShares$1.17 Million0.98% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...